Search Grant Opportunities

Strengthening Syringe Services Programs

ID: CDC-RFA-PS22-2208 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)

Description

This NOFO aims to increase access to harm reduction services for people who currently inject or have a history of injecting drugs (PWID) and reduce incidence of infectious diseases and complications of injection drug use through two components. Component 1 will expand a national network of syringe services programs (SSPs) to facilitate communication and networking among SSPs, other harm reduction programs, and trusted national organizations with a demonstrated portfolio in improving the health of persons who use drugs (PWUD). This component also improves data about SSPs by surveying SSPs to document capacity, needs, and service gaps. Component 2 will increase support and resources to SSPs for implementation of distribution of sterile injection supplies and disposal of used injection supplies; testing, treatment, and prevention of infectious diseases and infectious complications from injection drug use; and mitigation of other harms due to drug use. Applicants may apply for Component 1, Component 2, or both. Expected outcomes include: improved collaboration, communication, and data about SSPs nationwide; increased access to harm reduction services; decreased unsafe injection practices; decreased new infections of HCV, HBV, HAV, HIV, endocarditis, and other infections; decreased overdose rates and mortality; increased capacity for responding to outbreaks of infections associated with injection drug use; and increased services available through SSPs in the United States.
Background
This NOFO aims to increase access to harm reduction services for people who currently inject or have a history of injecting drugs (PWID) and reduce incidence of infectious diseases and complications of injection drug use through two components. Component 1 will expand a national network of syringe services programs (SSPs) to facilitate communication and networking among SSPs, other harm reduction programs, and trusted national organizations with a demonstrated portfolio in improving the health of persons who use drugs (PWUD). This component also improves data about SSPs by surveying SSPs to document capacity, needs, and service gaps.

Component 2 will increase support and resources to SSPs for implementation of distribution of sterile injection supplies and disposal of used injection supplies; testing, treatment, and prevention of infectious diseases and infectious complications from injection drug use; and mitigation of other harms due to drug use. Expected outcomes include: improved collaboration, communication, and data about SSPs nationwide; increased access to harm reduction services; decreased unsafe injection practices; decreased new infections of HCV, HBV, HAV, HIV, endocarditis, and other infections; decreased overdose rates and mortality; increased capacity for responding to outbreaks of infections associated with injection drug use; and increased services available through SSPs in the United States.

Grant Details
The overdose crisis has resulted in high rates of fatal1,2 and non-fatal2 overdose among persons who use drugs (PWUD); high rates of hepatitis C3, endocarditis4, outbreaks of HIV5 among persons who inject drugs (PWID) in the United States. Provision of sufficient sterile injection supplies for all injections and medications for opioid use disorder (MOUD) are associated with reductions in transmission of hepatitis C6 and HIV.7,8 Access to MOUD is associated with substantial reductions in all-cause9 mortality and overdose10,11 mortality. This funding opportunity seeks to improve the health of PWID by reducing incidence of hepatitis A, hepatitis B, hepatitis C, and HIV, the prevalence of hepatitis C, and overdose mortality among PWID in the United States.

Eligibility Requirements
Open Competition

Period of Performance
Total Period of Performance Funding: $50,000,000. Approximately $750,000 for Component 1. Approximately $9,250,000 for Component 2. Total Period of Performance Length: 5 years. Estimated Award Date: September 30, 2022

Grant Value
$50,000,000 total value. Average One Year Award Amount: $10,000,000

Place of Performance
United States
Show All

Overview

Agency
National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [HHS - CDC]
Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
93.488 - National Harm Reduction Technical Assistance and Syringe Services Program (SSP) Monitoring and Evaluation Funding Opportunity
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 3/1/22 National Center for HIV, Viral Hepatitis, STD, and TB Prevention posted grant opportunity CDC-RFA-PS22-2208 for Strengthening Syringe Services Programs with funding of $50.0 million. The grant will be issued under grant program 93.488 National Harm Reduction Technical Assistance and Syringe Services Program (SSP) Monitoring and Evaluation Funding Opportunity. It is expected that 2 total grants will be made.

Timing

Posted Date
March 1, 2022, 12:00 a.m. EST
Closing Date
May 2, 2022, 12:00 a.m. EDT Past Due
Closing Date Explanation
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Last Updated
March 2, 2022, 3:24 p.m. EST
Version
3
Archive Date
June 1, 2022

Eligibility

Eligible Applicants
Small businesses
Independent school districts
For profit organizations other than small businesses
Public and State controlled institutions of higher education
County governments
Public housing authorities/Indian housing authorities
Others (see text field entitled "Additional Information on Eligibility" for clarification)
City or township governments
Private institutions of higher education
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Info
 Applicants are invited to apply to one or two components, if desired. Applicants are permitted to submit only one application. If you are applying for both components, one application should be submitted with two separate narratives, workplans, and budgets required. CDC will not consider multiple applications from a single applicant.  The application will be considered as nonresponsive and will receive no further review if the requirements in this section are not met.

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$50,000,000
Estimated Number of Grants
2

Contacts

Contact
Centers for Disease Control - NCHHSTP
Contact Email
yno7@cdc.gov
Contact Phone
(770) 488-2756

Documents

Posted documents for CDC-RFA-PS22-2208

Grant Awards

Grants awarded through CDC-RFA-PS22-2208

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to CDC-RFA-PS22-2208